ストックスクリーナーアプリを入手
38.23
2.10%
-0.82
アフターアワーズ：
38.50
0.27
+0.71%
前日終値:
$39.05
開ける：
$39.05
24時間の取引高:
459.73K
Relative Volume:
0.67
時価総額：
$1.42B
収益：
$272.30M
当期純損益:
$-5.14M
株価収益率:
-233.82
EPS:
-0.1635
ネットキャッシュフロー:
$42.76M
1週間 パフォーマンス:
-6.53%
1か月 パフォーマンス:
+4.08%
6か月 パフォーマンス:
+12.67%
1年 パフォーマンス:
+62.06%
1日の値動き範囲:
$38.05
$39.29
1週間の範囲:
$38.05
$41.31
52週間の値動き範囲:
$21.12
$54.85
Harrow Inc Stock (HROW) Company Profile
Compare HROW vs TAK, TEVA, HLN, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
38.23 | 1.46B | 272.30M | -5.14M | 42.76M | -0.1635 |
TAK
Takeda Pharmaceutical Co Adr
|
16.46 | 52.57B | 29.85B | 776.90M | 4.35B | 0.2408 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.73 | 41.93B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.11 | 41.28B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
82.83 | 36.72B | 9.47B | 2.67B | 2.28B | 6.0218 |
UTHR
United Therapeutics Corp
|
564.94 | 24.16B | 3.18B | 1.33B | 1.04B | 27.90 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-11 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-06-12 | 開始されました | BTIG Research | Buy |
| 2025-06-10 | 開始されました | William Blair | Outperform |
| 2025-02-06 | 開始されました | H.C. Wainwright | Buy |
| 2024-12-04 | 繰り返されました | B. Riley Securities | Buy |
| 2024-04-11 | 開始されました | Craig Hallum | Buy |
| 2022-09-08 | 再開されました | B. Riley Securities | Buy |
| 2021-10-14 | 再開されました | B. Riley Securities | Buy |
| 2021-09-24 | 開始されました | Aegis Capital | Buy |
| 2021-07-02 | 開始されました | Ladenburg Thalmann | Buy |
すべてを表示
Harrow Inc (HROW) 最新ニュース
Harrow Q4 Earnings Fall, Revenue Rises - Moomoo
Harrow Health Inc stock (US4158581094): Recent share price move and earnings update - AD HOC NEWS
Harrow Inc (NASDAQ:HROW) Screens as a Strong Growth Stock with a Bullish Technical Setup - ChartMill
MSN Money - MSN
Analysts Estimate Harrow (HROW) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Record 2025 Results And Boosted Investment Could Be A Game Changer For Harrow (HROW) - Sahm
Harrow jumps as Cantor initiates with Bullish view on conservative outlook - MSN
Harrow, Inc. (NASDAQ:HROW) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Is Harrow, Inc. (HROW) A Good Stock To Buy Now? - Insider Monkey
Harrow announces $50M add-on senior notes offering - MSN
Harrow Inc (HROW) Stock Up 4.2% and Still Undervalued -- GF Scor - GuruFocus
Harrow To Report First Quarter 2026 Financial Results After Market Close on May 11, 2026 - GlobeNewswire
Harrow posts Q1 stockholder letter May 11, then webcasts call May 12 - Stock Titan
Executive pay and board structure at Harrow (NASDAQ: HROW) 2026 meeting - Stock Titan
Harrow | DEFA14A: Others - Moomoo
HROW News | HARROW INC (NASDAQ:HROW) - ChartMill
HROW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Harrow (HROW) Stock: Mistakes to Avoid (Underperforming) 2026-04-20Delta Trends - Xã Thanh Hà
Harrow: Now Is The Buy Time (NASDAQ:HROW) - Seeking Alpha
Harrow Inc (NASDAQ:HROW) Presents a Compelling Case for Affordable Growth - ChartMill
HROW Reiterated by BTIG -- Price Target Maintained at $63.00 - GuruFocus
Analysts Offer Insights on Healthcare Companies: Harrow Health (HROW) and BioCryst (BCRX) - The Globe and Mail
Harrow (NASDAQ:HROW) Given Buy Rating at BTIG Research - MarketBeat
Harrow Announces the Issuance of J-Code for IOPIDINE® 1% - Sahm
HROW Forecast, Price Target & Analyst Ratings | HARROW INC (NASDAQ:HROW) - ChartMill
Here's What Could Help Harrow (HROW) Maintain Its Recent Price Strength - Eastern Progress
Harrow Inc (HROW) Stock Up 4.8% and Still Undervalued -- GF Scor - GuruFocus
Harrow Secures Permanent J-Code for Iopidine 1% (HROW) - GuruFocus
Harrow (FRA:3IP) Shiller PE Ratio : (As of Apr. 17, 2026) - GuruFocus
Harrow Inc (FRA:3IP) Stock Price & 30 Year Financial Data - GuruFocus
Q3 2025 Harrow Inc Earnings Call Transcript - GuruFocus
Harrow Inc (FRA:3IP) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Eye drug used after laser procedures wins July reimbursement - Stock Titan
Does Harrow’s New LogiCare3PL Partnership (HROW) Reveal an Emerging Edge in Eyecare Distribution? - simplywall.st
Harrow: Now Is The Buy Time - Seeking Alpha
Harrow (HROW) Partners with LogiCare3PL for Distribution Services - GuruFocus
Harrow Selects LogiCare3PL as U.S. Distribution Partner for Ophthalmic Portfolio - citybiz
Harrow Taps LogiCare3PL as Distribution Partner - marketscreener.com
LogiCare3PL Selected as Distribution Partner by Harrow - ChartMill
Harrow: Probably A Short-Term Market Overreaction (NASDAQ:HROW) - Seeking Alpha
Harrow Inc (NASDAQ:HROW) Presents a Growth and Breakout Opportunity - ChartMill
Assessing Harrow (HROW) Valuation After US$8.1 Million In Recent Insider Stock Sales - Yahoo Finance
Harrow Inc (HROW) Stock Up 3.3% and Still Undervalued -- GF Scor - GuruFocus
Harrow Inc (HROW) 財務データ
収益
当期純利益
現金流量
EPS
1.49%
1.78%
大文字化:
|
ボリューム (24 時間):